Figure S1. Prophylactic autophagosome vaccination did not alter CD3 + CD4+ or CD3 + CD4 + FOXP3+ infiltrates from poly-I:C adjuvant only treatment. Figure S2. Overview of custom 4T1 mutation site peptide array. Figure S3. Vaccinated animals displayed increased IgG signals to 15mers and splenocyte IFNγ recognition of 15mer antigens. Figure S4. Increased IgG signal intensity to 4T1 15mers correlated with IgG signals in naïve animals. Figure S5. Antigens from proteins identified by mass spectrometry were not favored in IgG signal intensity increases. Figure S6. Increased post-vaccination IFNγ secretion in response to 4T1 mutation site peptides. Figure S7. Increased post-vaccination IFNγ secretion upon restimulation with 4T1 tumor cells. (DOCX ...
Class I HLA Tetramers and MCPyV peptide pools. Description of data: A) Summary of HLA and peptide co...
Figure S2. Initial response of splenic FDG uptake and T cells after a single vaccination (24Â h) dem...
Detection of specific-IgG, IgM or IgA immunoglobulin classes at the end of trial vaccinations (week ...
Figure S1. Representative gating strategy for the identification of neoantigen specific immune respo...
Figure S1. NF-κB activity was measured using cancer cell lysates to assess TLR4-expressing tumor cel...
Table S1.The tumor formation rate in mice immunized with HCC-vaccine. Figure S2. HCC-vaccine can act...
Figure S1. Effect of TLR agonists on the expression of rAd in DCs. DCs were transduced with rAdTet-o...
Figure S1. Activation of B3Z hybridoma after co-culture with D1 DCs loaded with 1uM of indicated com...
Provides the pictures for IHC staining for CD4, CD8 and CD11c in lymph nodes. (PDF 298Â kb
Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vac...
Figure S1. Immunization with MCMV-IE2-OVA induces vaccine-specific CD8+ T cell responses. (A) Mice w...
Flow cytometry gating for identification of tumour immune cell infiltrates. Singlets were identified...
Additional file 2: Figure S2. Detection of HPV16 E7-specific CD4+ T cell responses induced by TA-CIN...
Provides the pictures for IHC staining for CD80, CD86 and CD83 in lymph nodes. (PDF 445Â kb
Figure S3. Single cycle replication of MCMV based vectors induces anti-tumor effects. (A) Survival o...
Class I HLA Tetramers and MCPyV peptide pools. Description of data: A) Summary of HLA and peptide co...
Figure S2. Initial response of splenic FDG uptake and T cells after a single vaccination (24Â h) dem...
Detection of specific-IgG, IgM or IgA immunoglobulin classes at the end of trial vaccinations (week ...
Figure S1. Representative gating strategy for the identification of neoantigen specific immune respo...
Figure S1. NF-κB activity was measured using cancer cell lysates to assess TLR4-expressing tumor cel...
Table S1.The tumor formation rate in mice immunized with HCC-vaccine. Figure S2. HCC-vaccine can act...
Figure S1. Effect of TLR agonists on the expression of rAd in DCs. DCs were transduced with rAdTet-o...
Figure S1. Activation of B3Z hybridoma after co-culture with D1 DCs loaded with 1uM of indicated com...
Provides the pictures for IHC staining for CD4, CD8 and CD11c in lymph nodes. (PDF 298Â kb
Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vac...
Figure S1. Immunization with MCMV-IE2-OVA induces vaccine-specific CD8+ T cell responses. (A) Mice w...
Flow cytometry gating for identification of tumour immune cell infiltrates. Singlets were identified...
Additional file 2: Figure S2. Detection of HPV16 E7-specific CD4+ T cell responses induced by TA-CIN...
Provides the pictures for IHC staining for CD80, CD86 and CD83 in lymph nodes. (PDF 445Â kb
Figure S3. Single cycle replication of MCMV based vectors induces anti-tumor effects. (A) Survival o...
Class I HLA Tetramers and MCPyV peptide pools. Description of data: A) Summary of HLA and peptide co...
Figure S2. Initial response of splenic FDG uptake and T cells after a single vaccination (24Â h) dem...
Detection of specific-IgG, IgM or IgA immunoglobulin classes at the end of trial vaccinations (week ...